Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Xenadrine EFX manufacturer settles with FTC

This article was originally published in The Tan Sheet

Executive Summary

RTC Research and Development and the company's executives, husband and wife Robert Chinery Jr. and Tracy Chinery, settle in a case brought by the Federal Trade Commission for charges of false and unsubstantiated weight-loss claims related to their supplement Xenadrine EFX. In an April 24 release. FTC says it charged the defendants in 2005, and in 2006 the U.S. District Court for the District of New Jersey barred Robert Chinery and RTC from making claims and required RTC pay $8 million in consumer redress (1"The Tan Sheet" Aug. 13, 2007, In Brief). Tracy Chinery's motion to dismiss a similar settlement was denied in July 2007 and her motion for summary judgment was denied in March 2009, FTC says. The final settlement prohibits the Manasquan, N.J.-based firm and the Chinerys from "making any claims about the health benefits, performance, efficacy, safety, or side effects of any weight-loss product, dietary supplement, food, drug, or device" unless substantiated, true and not misleading. FTC says the defendants are not required to provide additional redress

You may also be interested in...

Xenadrine EFX refunds

The Federal Trade Commission will accept refund requests through Sept. 15 from consumers who were not satisfied with the product after buying it between Feb. 1, 2002 and May 22, 2006, the agency said in an Aug. 6 release. Under a settlement announced Jan. 4, Xenadrine EFX marketers Robert Chinery Jr., Tracey Chinery and RTC Research & Development LLC were required to pay as much as $12.8 million for consumer refunds after FTC alleged the product's weight-loss claims were false and unsubstantiated. Xenadrine EFX includes green tea extract and other caffeine sources (1"The Tan Sheet" Jan. 8, 2007, p. 4)...

China Lays Out Requirements For Biosimilar Extrapolation

In what could be a blow to some aspiring developers eyeing the nascent but growing biosimilars market in China, new rules lay out when extrapolation of approved indications of reference biologics will be allowed, meaning this will not be automatic.

Signs Of Hope But Obstacles Remain For Swiss Device MRA With EU

Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts